[Clinical application of beta-lactamase inhibitors on urinary tract infections].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000201:enzymology; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D010397:Penicillanic Acid / Q000627:therapeutic use*; D013407:Sulbactam; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D065093:beta-Lactamase Inhibitors
D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D004338:Drug Combinations; D065093:beta-Lactamase Inhibitors; D019818:Clavulanic Acid; D010397:Penicillanic Acid; D013407:Sulbactam